[Federal Register: December 10, 2002 (Volume 67, Number 237)]
[Notices]
[Page 75860-75861]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10de02-48]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30DAY-08-03]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 498-1210. Send written
comments to CDC, Desk Officer, Human Resources and Housing Branch, New
Executive Office Building, Room 10235, Washington, DC 20503. Written
comments should be received within 30 days of this notice.
Proposed Project: Human Exposure to Cyanobacterial (blue-green
algal) Toxins in Drinking Water: Risk of Exposure to Microcystin from
Public Water Systems (OMB. No. 0920-0527)--Revision--National Center
for Environmental Health (NCEH), Centers for Disease Control and
Prevention (CDC).
Background
Cyanobacteria (blue-green algae) can be found in terrestrial,
fresh, brackish, or marine water environments. Some species of
cyanobacteria produce toxins that may cause acute or chronic illnesses
(including neurotoxicity, hepatotoxicity, and skin irritation) in
humans and animals (including other mammals, fish, and birds). A number
of human health effects, including gastroenteritis, respiratory
effects, skin irritations, allergic responses, and liver damage, are
associated with the ingestion of or contact with water containing
cyanobacterial blooms. Although the balance of evidence, in conjunction
with data from laboratory animal research, suggests that cyanobacterial
toxins are responsible for a range of human health effects, however,
there have been few epidemiologic studies of this association. We plan
to recruit 100 people whose tap water comes from a source with a
current cyanobaterial bloom (i.e., M. aeruginosa) and who report
drinking unfiltered tap water. We also plan to recruit 100 people who
report drinking unfiltered tap water but whose tap water source is
groundwater that has not been contaminated with cyanobacteria. This
population will serve as our referent population for the analysis of
microcystins in blood and for the clinical assays. We will administer a
questionnaire and collect blood samples from all study participants.
Blood samples will be analyzed using a newly developed molecular assay
for levels of microcystins--the hepatotoxin produced by Micocystis
aeruginosa. We also will analyze blood samples for levels of liver
enzymes (a biological marker of hepatotoxicity) and for a number of
clinical parameters including hepatitis infection (a potential
confounder in our study). We will evaluate whether we can (1) detect
low levels of microcystins (<10 ng/ml of blood) in the blood of people
who are exposed to very low levels of this toxin in their drinking
water, (2) utilize clinical endpoints such as blood liver enzyme levels
as biomarkers of exposure and biological effect, and (3) compare the
analytical results for the exposed population with the results from the
referent population. The total annual burden hours is estimated to be
350.
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden/
Respondents Number of responses/ response (in
respondents respondent hrs.)
----------------------------------------------------------------------------------------------------------------
Telephone contact............................................... 300 1 10/60
Survey.......................................................... 200 1 1
[[Page 75861]]
Tap water sample collection..................................... 200 1 30/60
----------------------------------------------------------------------------------------------------------------
Dated: December 4, 2002.
John Moore,
Acting Deputy Director for Policy, Planning and Evaluation, Centers for
Disease Control and Prevention.
[FR Doc. 02-31133 Filed 12-9-02; 8:45 am]
BILLING CODE 4163-18-P